You are here

  • Home
  • Archive
  • Volume 66, Issue Suppl 2
  • PTU-082 Real world impact of rifaximin-Αlpha use in hepatic encephalopathy patients with advanced liver disease or continued alcohol misuse: a post-hoc analysis of the impress study

Article info

Article menu
Download PDFPDF
Liver
PTU-082 Real world impact of rifaximin-Αlpha use in hepatic encephalopathy patients with advanced liver disease or continued alcohol misuse: a post-hoc analysis of the impress study

Authors

Citation

Hudson M, Maggio PD, Cipelli R, et al
PTU-082 Real world impact of rifaximin-Αlpha use in hepatic encephalopathy patients with advanced liver disease or continued alcohol misuse: a post-hoc analysis of the impress study
Gut 2017;66:A92.

Publication history

  • First published June 17, 2017.
Online issue publication 
November 20, 2017

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© 2017, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions